Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

181 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta.
Land C, Rauch F, Montpetit K, Ruck-Gibis J, Glorieux FH. Land C, et al. J Pediatr. 2006 Apr;148(4):456-60. doi: 10.1016/j.jpeds.2005.10.041. J Pediatr. 2006. PMID: 16647404 Clinical Trial.
[Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases].
Semler O, Land C, Schönau E. Semler O, et al. Among authors: land c. Orthopade. 2007 Feb;36(2):146-51. doi: 10.1007/s00132-006-1037-4. Orthopade. 2007. PMID: 17252257 German.
High and low density in the same bone: a study on children and adolescents with mild osteogenesis imperfecta.
Rauch F, Land C, Cornibert S, Schoenau E, Glorieux FH. Rauch F, et al. Among authors: land c. Bone. 2005 Nov;37(5):634-41. doi: 10.1016/j.bone.2005.06.007. Epub 2005 Aug 19. Bone. 2005. PMID: 16112635
Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta.
Land C, Rauch F, Glorieux FH. Land C, et al. J Bone Miner Res. 2006 Mar;21(3):374-9. doi: 10.1359/JBMR.051207. Epub 2005 Dec 19. J Bone Miner Res. 2006. PMID: 16491284 Clinical Trial.
Forearm length - a new tool to standardize bone parameters of the forearm measured with peripheral quantitative computed tomography in individuals with disproportional growth of forearm length and body height.
Fricke O, Semler O, Beccard R, Land C, Ehrlich R, Remer T, Schoenau E. Fricke O, et al. Among authors: land c. Horm Res. 2009;72(3):172-7. doi: 10.1159/000232493. Epub 2009 Sep 1. Horm Res. 2009. PMID: 19729949
Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study.
Rauch F, Munns CF, Land C, Cheung M, Glorieux FH. Rauch F, et al. Among authors: land c. J Bone Miner Res. 2009 Jul;24(7):1282-9. doi: 10.1359/jbmr.090213. J Bone Miner Res. 2009. PMID: 19257821 Clinical Trial.
Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Land C, Rauch F, Travers R, Glorieux FH. Land C, et al. Bone. 2007 Mar;40(3):638-44. doi: 10.1016/j.bone.2006.10.010. Epub 2006 Nov 28. Bone. 2007. PMID: 17127117 Clinical Trial.
Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment.
Land C, Rauch F, Munns CF, Sahebjam S, Glorieux FH. Land C, et al. Bone. 2006 Oct;39(4):901-6. doi: 10.1016/j.bone.2006.04.004. Epub 2006 May 26. Bone. 2006. PMID: 16730480
Effect of pamidronate treatment on vertebral deformity in children with primary osteoporosis. A pilot study using radiographic morphometry.
Sumník Z, Land C, Rieger-Wettengl G, Körber F, Stabrey A, Schoenau E. Sumník Z, et al. Among authors: land c. Horm Res. 2004;61(3):137-42. doi: 10.1159/000075589. Epub 2003 Dec 15. Horm Res. 2004. PMID: 14676462
Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation.
Rauch F, Munns C, Land C, Glorieux FH. Rauch F, et al. Among authors: land c. J Clin Endocrinol Metab. 2006 Apr;91(4):1268-74. doi: 10.1210/jc.2005-2413. Epub 2006 Jan 24. J Clin Endocrinol Metab. 2006. PMID: 16434452 Clinical Trial.
181 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback